Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-030214

Director acquired 77,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

PERRY MICHAEL S · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2020-05-14 Exercise or conversion : show line 1 in the form +7,000 $4.75 $33,250 15,000 D
2020-05-14 Exercise or conversion : show line 2 in the form +5,000 $2.01 $10,050 20,000 D
2020-05-14 Exercise or conversion : show line 3 in the form +15,000 $2.19 $32,850 35,000 D
2020-05-14 Exercise or conversion : show line 4 in the form +10,000 $2.62 $26,200 45,000 D
2020-05-14 Exercise or conversion : show line 5 in the form +15,000 $5.19 $77,850 60,000 D
2020-05-14 Exercise or conversion : show line 6 in the form +25,000 $4.20 $105,000 85,000 D

Table II: Derivative

6 lines
Date Transaction Shares Owned after D/I
2020-05-14 Exercise or conversion : show line 7 in the form Common Stock (right to buy) −7,000 70,000 D
2020-05-14 Exercise or conversion : show line 8 in the form Common Stock (right to buy) −5,000 65,000 D
2020-05-14 Exercise or conversion : show line 9 in the form Common Stock (right to buy) −15,000 50,000 D
2020-05-14 Exercise or conversion : show line 10 in the form Common Stock (right to buy) −10,000 40,000 D
2020-05-14 Exercise or conversion : show line 11 in the form Common Stock (right to buy) −15,000 25,000 D
2020-05-14 Exercise or conversion : show line 12 in the form Common Stock (right to buy) −25,000 0 D
Loading xslF345X03/doc4.xml…